(Q47734996)

English

Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease

scientific article published on 22 May 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

0 references

Behçet's disease

0 references

0 references

1 reference

based on heuristic

inferred from title

Kazuyoshi Saito

2

object named as

Kazuyoshi Saito

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

author name string

Shigeru Iwata

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

Kunihiro Yamaoka

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

Shizuyo Tsujimura

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

Masao Nawata

5

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

Katsunori Suzuki

6

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

Yoshiya Tanaka

7

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

publication date

22 May 2009

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

48

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

8

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

1012-1013

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP126

21 January 2018

Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapy

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP126

21 January 2018

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP126

21 January 2018

Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP126

21 January 2018

Identifiers

10.1093/RHEUMATOLOGY/KEP126

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19465589

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47734996&oldid=2167972876"